文献速递前列腺癌

当代大型多样化人群中前列腺癌登记研究的生活质量结局

Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population.
PubMed 文献 · BJU Int · 2017-04-19

该研究纳入2011年3月至2014年1月新诊断的前列腺癌患者5727例,采用EPIC-26问卷在治疗前及治疗后1、3、6、12、18、24个月评估健康相关生活质量。结果显示不同治疗方式的生活质量变化不同,RALP患者性功能恢复最好,但术后24个月尿失禁仍比其他治疗方式差。

要点

  • 治疗后1个月,放疗患者肠道评分最低,近距离放疗患者泌尿刺激症状评分最低。
  • 所有治疗方式均出现性功能下降,手术下降最陡,ORP下降大于RALP。
  • RALP患者性功能恢复较好,24个月时接近近距离放疗和放疗。

核心结论

  • 前列腺癌治疗后的健康相关生活质量因治疗方式而异,RALP患者性功能恢复最多,但术后24个月尿失禁仍比其他治疗方式差。

研究设计与样本

  • 研究纳入2011年3月至2014年1月在本医疗系统内新诊断的前列腺癌患者,共5727例。
  • 采用EPIC-26问卷在治疗前及治疗后1、3、6、12、18、24个月评估所有治疗方式患者的生活质量,随访至2014年11月。
  • 使用Kruskal-Wallis检验比较各时间点EPIC-26各领域评分的分布,并用混合模型评估治疗后各领域总体评分。

主要发现

  • 治疗前及治疗后1、3、6、12、18、24个月分别有3422、2329、2017、1922、1772、1260、837例患者的数据。
  • 治疗后1个月,放疗患者肠道评分最低,近距离放疗患者泌尿刺激症状评分最低。
  • 所有治疗方式均出现性功能下降,手术下降最陡,且ORP下降大于RALP。
  • RALP患者性功能恢复较好,24个月时接近近距离放疗和放疗。
  • 尿失禁在手术患者中下降最多,RALP患者在12-24个月略优于ORP患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the health-related quality of life (HRQoL) of patients with prostate cancer up to 24 months after treatment in a contemporary large diverse population. PATIENTS AND METHODS: Patients with newly diagnosed prostate cancer from March 2011 to January 2014 in our healthcare system were included. The Expanded Prostate Cancer Index Composite (EPIC-26) questionnaire was administered before treatment, and at 1, 3, 6, 12, 18, and 24 months after treatment up to November 2014 for all methods of treatment. The Kruskall-Wallis test was used to compare the distribution of each EPIC-26 domain score at each time point, and mixed models were used to assess the overall scores over the period after treatment. RESULTS: In all, 5 727 patients were included. There were data for 3 422, 2 329, 2 017, 1 922, 1 772, 1 260, and 837 patients before treatment, and at 1, 3, 6, 12, 18, and 24 months after treatment, respectively. At 1 month, bowel scores were the lowest for patients that had had radiation therapy, and urinary irritative symptoms were the lowest for those who had had brachytherapy. There were sexual function declines for all the treatment methods, with surgery having the steepest decline; open radical prostatectomy (ORP) had a greater decline than robot-assisted laparoscopic prostatectomy (RALP). Patients who underwent RALP had a better return of sexual function, approaching that of brachytherapy and radiation therapy at 24 months. Urinary incontinence (UI) also declined the most in surgical patients, with RALP patients improving slightly more than ORP patients at 12-24 months. CONCLUSIONS: Patients' HRQoL after prostate cancer treatment varies by treatment method. Notably, sexual function recovers most for RALP patients. UI remains worse at 24 months after surgery, compared to other methods of prostate cancer treatment.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Chien GW, Slezak JM, Harrison TN, et al. Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population. BJU Int. 2017. PMID: 28425193. doi:10.1111/bju.13843

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。